Skip to main content
See every side of every news story
Published • loading... • Updated

Orforglipron May Lower Apnea Hypopnea Index for Sleep Apnea

San Diego – The oral GLP-1 receptor agonist (GLP-1-RA) orforglipron can alleviate sleep apnea. The data from the ATTAIN-OSA studies presented at the American Heart Association (AHA) Annual Meeting in Chicago show a decrease in the Apnea-Hypopnea Index (AHI). Results were reported simultaneously in JAMA (2026; DOI: 10.1001/jama.2026.24080)...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

San Diego – The oral GLP-1 receptor agonist (GLP-1-RA) orforglipron can alleviate sleep apnea. The data from the ATTAIN-OSA studies presented at the American Heart Association (AHA) Annual Meeting in Chicago show a decrease in the Apnea-Hypopnea Index (AHI). Results were reported simultaneously in JAMA (2026; DOI: 10.1001/jama.2026.24080)...

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Deutsches Ärzteblatt broke the news on Monday, November 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal